Skip to content

Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)

Evaluation of Regeneten Augmentation for Subscapularis Healing After Total Shoulder Arthroplasty (RESTOR)

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04861714
Enrollment
75
Registered
2021-04-27
Start date
2020-07-14
Completion date
2027-04-30
Last updated
2025-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arthroplasty, Replacement, Shoulder

Brief summary

The purpose of this study is to evaluate whether augmentation of subscapularis repair with the Regeneten implant after anatomic total shoulder arthroplasty (TSA) can improve rates of subscapularis healing and improve clinical outcomes.

Detailed description

Subscapularis management is an area of controversy in the literature for total shoulder arthroplasty (TSA). Regeneten has been suggested as a bioinductive implant to aid in rotator cuff healing. We hypothesize that applying this technology could aid in obtaining higher rates of subscapularis healing for TSA when utilizing SP or ST, which in turn could lead to improved outcomes.The 50 randomized subjects will be randomized at a 1:1 ratio into the standard subscapularis repair group or the standard repair with Regeneten augmentation group. Subjects will be blinded to their treatment assignment until they complete all study visits. Upon withdraw from the study, termination from the study, or new or recurrent symptoms requiring a subsequent surgical procedure, the blinded assignment will be revealed to the subject. Subjects will be assessed pre-operatively and return post-operatively at Week 2, Weeks 6, Month 3, Month 6, and Year 1. The primary outcome will evaluate subscapularis repair integrity and healing at one year post-op.

Interventions

DEVICERegeneten

Augmentation of standard subscapularis repair with regeneten patch

PROCEDUREStandard repair

Standard subscapularis repair

Sponsors

Smith & Nephew, Inc.
CollaboratorINDUSTRY
Ohio State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients healthy enough to undergo primary anatomic TSA 2. Being treated with subscapularis tenotomy or subscapularis peel. 3. Age 50 or above 4. Intact rotator cuff including subscapularis as determined by preoperative examination and imaging (typically preoperative CT, MRI if indicated or available).

Exclusion criteria

1. Revision arthroplasty 2. Reverse arthroplasty 3. Requiring a lesser tuberosity osteotomy 4. Intraoperative identification of rotator cuff tear requiring repair 5. Object to using cow derived material 6. Prior index shoulder surgery requiring treatment to the subscapularis

Design outcomes

Primary

MeasureTime frameDescription
Subscapularis repair integrity assessed by lift-off test using dynamometry.12 months post-opPounds (lbs) of force that the subject can produce during the lift off test will be recorded.

Secondary

MeasureTime frameDescription
Abduction active range of motion as assessed by treating physician6 weeksThe amount of abduction range of motion will be reported in degrees from 0-180.
External rotation active range of motion as assessed by treating physician6 weeksThe amount of external rotation range of motion will be reported in degrees from 0-180.
Internal rotation active range of motion as assessed by treating physician6 weeksThe amount of internal rotation range of motion will be reported in vertebrae level the thumb reaches from 0, 0°; 1, hip; 2, buttocks; 3, sacrum; 4, L4-L5; 5, L1-L3; 6, T8-T12; 7, T7 or higher.
Patient reported clinical outcome scores on the American Shoulder and Elbow Surgeon Evaluation (ASES)6 weeksThe American Shoulder and Elbow Surgeons (ASES) score is composed of a patient-reported portion and a physician assessment.The ASES tool includes a patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.
Forward elevation active range of motion as assessed by treating physician6 weeksThe amount of forward elevation range of motion will be reported in degrees from 0-180.
Patient reported clinical outcome scores- Visual Analog Scale (VAS)6 weeksThe visual analog scale for pain is a straight line with one end meaning no pain and the other end meaning the worst pain imaginable. A patient marks a point on the line that matches the amount of pain he or she feels. Score ranges from 0-100mm where 0mm= no pain and 100mm=extreme pain.
Patient reported clinical outcome scores- Simple shoulder test (SST)6 weeksThe simple shoulder test is a series of 12 yes or no questions the patient answers about the function of the involved shoulder. Answers of 'yes' receive a score of 1 and answers of 'no' receive a score of 0. Scores range from 0-12 where 0=no function and 12=full function.
Patient reported clinical outcome scores- Simple shoulder value (SST)6 weeksThe simple shoulder value is defined as a patient's subjective shoulder assessment expressed as a percentage of an entirely normal shoulder, which would score 100%.
Patient reported clinical outcome scores- American Shoulder and Elbow Surgeon Evaluation (ASES)12 monthsThe American Shoulder and Elbow Surgeons (ASES) score is composed of a patient-reported portion and a physician assessment.The ASES tool includes a patient-reported score with visual analog scale for pain and functional subscales ranging from 0 (worse pain and function loss) to 50 (no pain and excellent function). Both scores are summed for a maximum score of 100.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026